Literature DB >> 7712329

Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene.

L Cordier1, M T Duffour, J C Sabourin, M G Lee, J Cabannes, T Ragot, M Perricaudet, H Haddada.   

Abstract

Direct introduction of exogenous genes into pre-existent tumors could provide an effective therapeutic approach for treatment of localized tumors. In this report we show that direct intratumoral delivery in animals of a replication-deficient adenovirus vector harboring the murine interleukin (IL)-2 gene (AD-mIL2) causes complete disappearance of P815 murine mastocytoma tumors in up to 75% of cases. Histological analysis of treated tumors revealed the presence of several zones of necrosis and the infiltration of macrophages and T cells. Moreover, the successfully treated animals develop a long lasting state of immunity during which further challenges with the tumor cells are rejected. To our knowledge this is the first successful in vivo treatment of an established tumor using adenoviral gene therapy methods.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712329

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  13 in total

1.  Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma.

Authors:  Mikko Siurala; Riikka Havunen; Dipongkor Saha; Dave Lumen; Anu J Airaksinen; Siri Tähtinen; Víctor Cervera-Carrascon; Simona Bramante; Suvi Parviainen; Markus Vähä-Koskela; Anna Kanerva; Akseli Hemminki
Journal:  Mol Ther       Date:  2016-06-30       Impact factor: 11.454

Review 2.  Anti-tumor gene therapy.

Authors:  C Cirielli; M C Capogrossi; A Passaniti
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 3.  Non-replicating expression vectors: applications in vaccine development and gene therapy.

Authors:  K J Limbach; E Paoletti
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

Review 4.  The promise and reality of cancer gene therapy.

Authors:  S J Hall; S H Chen; S L Woo
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

Review 5.  New therapeutic approaches based on gene transfer techniques.

Authors:  H Chong; R G Vile
Journal:  Springer Semin Immunopathol       Date:  1996

Review 6.  The Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeutics.

Authors:  R G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  1995

Review 7.  Tumor cells engineered to produce cytokines or cofactors as cellular vaccines: do animal studies really support clinical trials?

Authors:  M P Colombo; M Rodolfo
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

Review 8.  Strategies for cancer gene therapy using adenoviral vectors.

Authors:  V Descamps; M T Duffour; M C Mathieu; N Fernandez; L Cordier; M A Abina; E Kremer; M Perricaudet; H Haddada
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

9.  Adenovirus mediated gene therapy in a glioblastoma vaccine model; specific antitumor immunity and abrogation of immunosuppression.

Authors:  A M Donson; N K Foreman
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

10.  Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.

Authors:  C L Addison; T Braciak; R Ralston; W J Muller; J Gauldie; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.